Skip to content

Serum Immunoassay for Anti-Mitochondrial Antibodies (AMA-Serum)

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies directed against mitochondrial proteins, often used to help diagnose primary biliary cholangitis (PBC), a rare autoimmune liver disease.

Quick summary

["Helps diagnose liver conditions by detecting specific immune system responses."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
6368-5
Short code
C immitis Ab Titr Ser LA
Synonyms
C immitis Ab Titr Ser LA
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
la
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Is Primary Biliary Cholangitis (PBC)?

Primary biliary cholangitis (PBC) is an autoimmune disease where the immune system mistakenly attacks the bile ducts in the liver. Over time, this can cause inflammation, scarring, and damage to the liver. Symptoms may include fatigue, itching, jaundice (yellowing of skin/eyes), and digestive issues like bloating or nausea.

Why Might This Test Be Ordered?

Your healthcare provider may order this test if you have symptoms of liver disease, such as persistent itching, jaundice, or unexplained fatigue. It’s also used to confirm a diagnosis of PBC or monitor disease activity in patients already diagnosed.

How Is the Test Performed?

A blood sample is drawn from a vein in your arm. The serum (liquid part of blood after clotting) is then tested using an immunoassay method to detect the presence of anti-mitochondrial antibodies. Results are reported as positive or negative, or sometimes with a semi-quantitative measurement of antibody levels.

What Do the Results Mean?

A positive result strongly suggests PBC, though other liver conditions or autoimmune diseases may sometimes yield false positives. A negative result means the test did not detect these antibodies, which may rule out PBC but doesn’t rule out other liver issues entirely.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

AMA-Serum

Frequently asked questions

How often will I need this test?
If you are diagnosed with PBC, your doctor may order this test periodically to monitor disease progression or response to treatment. Frequency depends on your symptoms, liver function tests, and overall health. Follow-up may include additional blood tests or liver imaging.
What are the possible side effects of the blood draw?
The most common side effect of a blood draw is mild bruising, soreness, or swelling at the injection site. Rarely, you might experience a slight fainting sensation or dizziness. To minimize discomfort, ask your healthcare provider to apply a cold compress or take it easy for a few hours afterward.
Can I eat or drink before this test?
You can eat and drink normally before this test unless instructed otherwise by your doctor. No special preparation is typically needed, but always confirm with your healthcare provider to avoid any potential delays or complications.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy